This opportunity has been awarded. Its page stays for reference.
Similar open opportunities
- Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Apixaban (ATC-Code nach WHO: B01AF02)
- Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Natalizumab (ATC-Code nach WHO: L04AG03)
- Ausschreibung Patientenmonitoring
- Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Infliximab zur subkutanen Injektion (ATC-Code nach WHO: L04AB02)
- Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Tocilizumab (ATC-Code nach WHO: L04AC07)
Abschluss eines nicht-exklusiven Rabattvertrages gemäß§ 130c Abs. 1 SGB V zwischen der IKK classic und Abacus Medicine und Originalis B.V. zu Bimzelx
At a glance
IKK classic is procuring Pharmaceutical products (CPV 33600000) in Dresden, Kreisfreie Stadt (DED21). It has been awarded. Procedure type: Negotiated without prior call for competition.
From the notice
Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und Abacus Medicine und Originalis B.V. zu Bimzelx (Wirkstoff: Bimekizumab, ATC-Code: L04AC21, Vertragslaufzeit: 01.10.2026-30.09.2028)
Key facts
Each fact is from the official notice, last checked 4 November 2026, 12:10 (UTC+01:00).
- Status
- AwardedOfficial notice · checked 4 Nov 2026, 12:10 (UTC+01:00)
- Deadline
- No deadline in the noticeOfficial notice · checked 4 Nov 2026, 12:10 (UTC+01:00)
- Buyer
- IKK classic, Dresden, DEOfficial notice · checked 4 Nov 2026, 12:10 (UTC+01:00)
- Place of performance
- Dresden, Kreisfreie Stadt (DED21)Official notice · checked 4 Nov 2026, 12:10 (UTC+01:00)
- Main CPV
- Pharmaceutical products (CPV 33600000)Official notice · checked 4 Nov 2026, 12:10 (UTC+01:00)
- Procedure
- Negotiated without prior call for competitionOfficial notice · checked 4 Nov 2026, 12:10 (UTC+01:00)
- Lots
- 1Official notice · checked 4 Nov 2026, 12:10 (UTC+01:00)
- First published
- 30 October 2026, 12:40 (UTC+01:00)Official notice · checked 4 Nov 2026, 12:10 (UTC+01:00)
Fact sheet

Lots (1)
Lot LOT-0000: Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und Abacus Medicine und Originalis B.V. zu Bimzelx
Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und Abacus Medicine und Originalis B.V. zu Bimzelx (ATC-Code: L04AC21, Vertragslaufzeit: 01.10.2026-30.09.2028)
Timeline
- Award: Award. Winner: Abacus Medicine; Award value: €1 excl. VAT; Tenders received: 1; Lot LOT-0000.
- Award: Award. Winner: Originalis B.V.; Award value: €1 excl. VAT; Tenders received: 1; Lot LOT-0000.
- 30 October 2026, 12:40 (UTC+01:00): Award notice Notice, version 01 (Contract or concession award notice – standard regime). Official notice
- 30 October 2026, 12:40 (UTC+01:00): Award notice Notice, version 01 (Contract or concession award notice – standard regime). Official notice
Buyer and place
Buyer
IKK classic
Dresden, DE
Place of performance
- Dresden, Kreisfreie Stadt (DED21)
Other parties in the notice
- Abacus Medicine (Tenderer), Copenhagen
- Originalis B.V. (Tenderer), Amsterdam
- Abacus Medicine (Winner), Copenhagen
- Originalis B.V. (Winner), Amsterdam
Classification
CPV codes
- 33600000: Pharmaceutical products
NUTS regions
- DED21: Dresden, Kreisfreie Stadt
Official documents
No documents found in the indexed notice.
Questions and answers
Who is the buyer?
IKK classic, Dresden, DE.
What is being procured (CPV)?
Pharmaceutical products (CPV 33600000).
Where is the work performed (NUTS)?
Dresden, Kreisfreie Stadt (DED21).
Is it divided into lots?
No, the notice names a single lot.
Which procedure is used?
Negotiated without prior call for competition.
How do I submit a bid?
On the official notice or the portal it names. Inteliwert does not submit bids. Official notice
Am I eligible?
Inteliwert does not judge eligibility. The selection criteria are in the official notice. Official notice
More from this buyer
Other published opportunities of this buyer in the indexed notices, open ones first.
-
AwardedTender
Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130a Abs. 8 SGB V zwischen der IKK classic und der Besins Healthcare Germany GmbH zu Testogel
Last checked 6 Nov 2026, 07:11 (UTC+01:00)Official notice
Source
- Publisher
- Bekanntmachungsservice
- Licence
- CC0 1.0
- Last checked
- 4 November 2026, 12:10 (UTC+01:00)
The official notice is authoritative. Inteliwert shows what the notice states and links to it.